United Therapeutics Corp (NASDAQ:UTHR)
During the Trading Day
| 65.67 |  +0.91 / +1.41% |
Data as of 3:59pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 65.67 |  0.00 / 0.00% |
Volume: 5.5K |
Latest UTHR News | Press Releases
| Setback for Pluristem Therapeutics - Analyst Blog Jun 05 / Zacks.com |
Today’s Trading
| Previous close | 64.76 |
| Today’s open | 64.80 |
| Day’s range | 64.41 - 65.88 |
| Volume | 265,541 |
| Average volume (3 months) | 730,104 |
| Market cap | $3.2B |
| Dividend yield | -- |
Data as of 3:59pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | +56.12% |
| Earnings growth (this year) | +3.47% |
| Earnings growth (next 5 years) | +40.00% |
| Revenue growth (last year) | +22.99% |
| P/E ratio | 11.7 |
| Price/Sales | 3.04 |
| Price/Book | 3.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| THRXTheravance Inc | +0.30 | +0.85% |
| MDVNMedivation Inc | +1.34 | +2.83% |
| INCYIncyte Corp | +0.35 | +1.66% |
| QCORQuestcor Pharmaceuti... | +0.74 | +1.64% |
Data as of 4:00pm ET, 06/18/2013
Financials
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | $1.47 |
| Annual revenue (last year) | $914.1M |
| Annual profit (last year) | $304.4M |
| Net profit margin | 33.31% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Martine A. Rothblatt, PhD, MBA |
President, Chief Operating Officer & Director Roger Jeffs, PhD |
Corporate headquarters Silver Spring, Maryland |
Forecasts
